Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Burkitt lymphoma of the ovaries mimicking sepsis: a case report and review of the literature

Authors: Athanasios Gravos, Konstantinos Sakellaridis, Paraskeui Tselioti, Konstantina Katsifa, Varvara Grammatikopoulou, Aikaterini Nodarou, Κonstantinos Sarantos, Alexandros Tourtoglou, Eirini Tsovolou, Charilaos Tsapas, Athanasios Prekates

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

It is not unusual for systemic diseases to mimic sepsis and, in any case, the clinician should thoroughly investigate this possibility.

Case presentation

We present the case of a 21-year-old Greek woman who presented to the Intensive Care Unit of our hospital with severe septic shock – multiple organ failure as a result of a suspected gynecological infection of the ovaries. An immediate improvement of her clinical condition in combination with strong clinical suspicion and negative cultures led to the differential diagnosis of diseases other than sepsis. Based on the results of the biopsies that were obtained by research laparotomy, our patient suffered from primary Burkitt ovarian lymphoma. Her clinical condition improved with supportive treatment and chemotherapy. Chemotherapy is the dominant treatment for Burkitt’s lymphoma, while surgery or radiotherapy has no place.

Conclusions

All intensivists should be aware of clinical conditions that mimic sepsis as early diagnosis can lead to appropriate therapy and avoid unnecessary diagnostic tests and antibiotic abuse.
Literature
2.
go back to reference Lu S-C, Shen W-L, Cheng Y-M, et al. Burkitt’s lymphoma as a primary gynecologic tumor. Taiwan J Obstet Gynecol. 2006;45:162–6.CrossRef Lu S-C, Shen W-L, Cheng Y-M, et al. Burkitt’s lymphoma as a primary gynecologic tumor. Taiwan J Obstet Gynecol. 2006;45:162–6.CrossRef
3.
go back to reference Gutiérrez-García L, Medina Ramos N, García Rodríguez R, et al. Bilateral ovarian Burkitt's lymphoma. Eur J Gynaecol Oncol. 2009;30(2):231–3.PubMed Gutiérrez-García L, Medina Ramos N, García Rodríguez R, et al. Bilateral ovarian Burkitt's lymphoma. Eur J Gynaecol Oncol. 2009;30(2):231–3.PubMed
4.
go back to reference Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11(4):375–83.CrossRef Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11(4):375–83.CrossRef
5.
go back to reference McMaster ML, Greer JP, Greco FA, et al. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol. 1991;9(6):941–6.CrossRef McMaster ML, Greer JP, Greco FA, et al. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol. 1991;9(6):941–6.CrossRef
6.
go back to reference Myrianthefs P, Ladakis C, Lappas V, et al. Ovarian hyperstimulation syndrome (OHSS): diagnosis and management. Intensive Care Med. 2000;26(5):631–4.CrossRef Myrianthefs P, Ladakis C, Lappas V, et al. Ovarian hyperstimulation syndrome (OHSS): diagnosis and management. Intensive Care Med. 2000;26(5):631–4.CrossRef
7.
go back to reference Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod. 1997;12(6):1129–37.CrossRef Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod. 1997;12(6):1129–37.CrossRef
8.
go back to reference Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993;8(9):1353–60.CrossRef Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993;8(9):1353–60.CrossRef
9.
go back to reference Rutkowski A, Dubinsky I. Ovarian hyperstimulation syndrome: imperatives for the emergency physician. J Emerg Med. 1999;17(4):669–72.CrossRef Rutkowski A, Dubinsky I. Ovarian hyperstimulation syndrome: imperatives for the emergency physician. J Emerg Med. 1999;17(4):669–72.CrossRef
10.
go back to reference Friedman AS, Friedberg JW, Aster JC. In: Lister A, Connor RF, editors. Clinical Presentation and diagnosis of non-Hodgkin’s lymphoma. Up To Date. USA: Wolters Kluver; 2015. www.uptodate.com. Friedman AS, Friedberg JW, Aster JC. In: Lister A, Connor RF, editors. Clinical Presentation and diagnosis of non-Hodgkin’s lymphoma. Up To Date. USA: Wolters Kluver; 2015. www.​uptodate.​com.
11.
go back to reference Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 262–4. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 262–4.
12.
go back to reference Armitage JO. Staging non-Hodgkin Lymphoma. Cancer J Clin. 2009;55(6):368–76.CrossRef Armitage JO. Staging non-Hodgkin Lymphoma. Cancer J Clin. 2009;55(6):368–76.CrossRef
13.
go back to reference Todeschini G, Bonifacio M, Tecchio C, et al. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia. Am J Hematol. 2012;87(1):22–5.CrossRef Todeschini G, Bonifacio M, Tecchio C, et al. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia. Am J Hematol. 2012;87(1):22–5.CrossRef
14.
go back to reference Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106(7):1569–80.CrossRef Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106(7):1569–80.CrossRef
15.
go back to reference Havelange V, Pepermans X, Ameye G, et al. Genetic differences between paediatric and adult Burkitt lymphomas. Br J Haematol. 2016;173(1):137–44.CrossRef Havelange V, Pepermans X, Ameye G, et al. Genetic differences between paediatric and adult Burkitt lymphomas. Br J Haematol. 2016;173(1):137–44.CrossRef
16.
go back to reference Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104(10):3009–20.CrossRef Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104(10):3009–20.CrossRef
Metadata
Title
Burkitt lymphoma of the ovaries mimicking sepsis: a case report and review of the literature
Authors
Athanasios Gravos
Konstantinos Sakellaridis
Paraskeui Tselioti
Konstantina Katsifa
Varvara Grammatikopoulou
Aikaterini Nodarou
Κonstantinos Sarantos
Alexandros Tourtoglou
Eirini Tsovolou
Charilaos Tsapas
Athanasios Prekates
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-018-1828-3

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue